Shares of Oxford Cannabinoid Technologies Holdings Plc (LON:OCTP – Get Free Report) dropped 66.6% during trading on Wednesday . The stock traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.12 ($0.00). Approximately 33,863,473 shares changed hands during trading, an increase of 515% from the average daily volume of 5,502,056 shares. The stock had previously closed at GBX 0.35 ($0.00).
Oxford Cannabinoid Technologies Trading Down 64.6 %
The company has a market cap of £1.35 million, a PE ratio of -53.10 and a beta of 0.79. The business’s 50 day moving average is GBX 0.40 and its two-hundred day moving average is GBX 0.57.
About Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.
Featured Articles
- Five stocks we like better than Oxford Cannabinoid Technologies
- How Investors Can Find the Best Cheap Dividend Stocks
- Garmin Navigates to New Highs Driven By Wearables Trend
- Quiet Period Expirations Explained
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
